Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6808)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 21, 2021 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zarębska-Michaluk D. Genotype 3-hepatitis C virus’ last line of defense. World J Gastroenterol 2021; 27(11): 1006-1021 [PMID: 33776369 DOI: 10.3748/wjg.v27.i11.1006] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v27/i11/1006.htm |
| Number | Citing Articles |
| 1 |
Priyanka Shukla Bajpai, Laura Collignon, Christina Sølund, Lone Wulff Madsen, Peer Brehm Christensen, Anne Øvrehus, Nina Weis, Kenn Holmbeck, Ulrik Fahnøe, Jens Bukh, J.-H. James Ou.
Full-length sequence analysis of hepatitis C virus genotype 3b strains and development of an
in vivo
infectious 3b cDNA clone
. Journal of Virology 2023; 97(12) doi: 10.1128/jvi.00925-23
|
| 2 |
Wesal Elgretli, Tianyan Chen, Nadine Kronfli, Giada Sebastiani. Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact. Biomedicines 2023; 11(2): 271 doi: 10.3390/biomedicines11020271
|
| 3 |
Jennifer J. Lin, Catrina M. Loucks, Jessica N. Trueman, Britt I. Drögemöller, Galen E.B. Wright, Eric M. Yoshida, Jo-Ann Ford, Samuel S. Lee, Richard B. Kim, Bandar Al-Judaibi, Ute I. Schwarz, Alnoor Ramji, Edward Tam, Colin J. Ross, Bruce C. Carleton. Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment. Biomedicine & Pharmacotherapy 2021; 143: 112195 doi: 10.1016/j.biopha.2021.112195
|
| 4 |
Ligita Jančorienė, Baiba Rozentāle, Ieva Tolmane, Agita Jēruma, Riina Salupere, Arida Buivydienė, Jonas Valantinas, Limas Kupčinskas, Jolanta Šumskienė, Eglė Čiupkevičienė, Arvydas Ambrozaitis, Olga Golubovska, Larysa Moroz, Robert Flisiak, Borys Bondar. Genotype Distribution and Characteristics of Chronic Hepatitis C Infection in Estonia, Latvia, Lithuania, and Ukraine: The RESPOND-C Study. Medicina 2023; 59(9): 1577 doi: 10.3390/medicina59091577
|
| 5 |
Ru Xu, Xia Rong, Elihu Aranday-Cortes, Sreenu Vattipally, Joseph Hughes, John McLauchlan, Yongshui Fu. The Transmission Route and Selection Pressure in HCV Subtype 3a and 3b Chinese Infections: Evolutionary Kinetics and Selective Force Analysis. Viruses 2022; 14(7): 1514 doi: 10.3390/v14071514
|
| 6 |
Shuang Zhou, Karen Qi, Susan J. Bersoff‐Matcha, Poonam Mishra, Kimberly Struble. Sex‐related difference analyses of efficacy and safety in clinical trials of direct‐acting antivirals to treat chronic HCV genotype 1 and 3 infections. Journal of Viral Hepatitis 2024; 31(2): 78 doi: 10.1111/jvh.13901
|
| 7 |
Hsuan-Yu Hung, Hui-Hsiung Lai, Hui-Chuan Lin, Chung-Yu Chen. The impact of sofosbuvir/velpatasvir/voxilaprevir treatment on serum hyperglycemia in hepatitis C virus infections: a systematic review and meta-analysis. Annals of Medicine 2023; 55(1): 463 doi: 10.1080/07853890.2023.2168745
|
| 8 |
Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Anna Parfieniuk-Kowerda, Ewa Janczewska, Dorota Dybowska, Małgorzata Pawłowska, Waldemar Halota, Włodzimierz Mazur, Beata Lorenc, Justyna Janocha-Litwin, Krzysztof Simon, Anna Piekarska, Hanna Berak, Jakub Klapaczyński, Piotr Stępień, Barbara Sobala-Szczygieł, Jolanta Citko, Łukasz Socha, Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz, Marek Sitko, Beata Dobracka, Rafał Krygier, Jolanta Białkowska-Warzecha, Łukasz Laurans, Robert Flisiak. Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics. Journal of Clinical Medicine 2021; 10(15): 3280 doi: 10.3390/jcm10153280
|
| 9 |
Jing Zhou, Fa-Da Wang, Lan-Qing Li, Jing-Yu Li, En-Qiang Chen. Decreased efficacy of sofosbuvir/velpatasvir in HIV patients coinfected with HCV genotype 3b. Future Virology 2024; 19(1): 33 doi: 10.2217/fvl-2023-0112
|